Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
CHEO Genetics Diagnostic Laboratory, |
RCV001799185 | SCV002042451 | uncertain significance | Cardiomyopathy | 2021-03-17 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV001810330 | SCV002059402 | uncertain significance | Early-onset myopathy with fatal cardiomyopathy | 2019-02-07 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV002473299 | SCV002770618 | uncertain significance | not provided | 2022-05-20 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002478029 | SCV002780069 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-10-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV002473299 | SCV005442985 | uncertain significance | not provided | 2024-07-03 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss-of-function; Has not been previously published as pathogenic or benign to our knowledge |